Skip to main content
. 2019 Oct 13;94(12):1353–1363. doi: 10.1002/ajh.25638

Figure 1.

Figure 1

Progression‐free survival (A) in the ITT population and (B) in the high‐risk population (patients with del(17p), TP53 mutation, del(11q), and/or unmutated IGHV status). (C) Forest plot of HRs for progression‐free survival by baseline subgroups (ITT population). CI, confidence interval; ECOG, Eastern Cooperative Oncology Group; IGHV, immunoglobulin heavy‐chain variable region gene; ITT, intention‐to‐treat; PFS, progression‐free survival.

*Patients with del(17p), TP53 mutation, del(11q), and/or unmutated IGHV status